IL58673A - Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same - Google Patents
Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing sameInfo
- Publication number
- IL58673A IL58673A IL58673A IL5867379A IL58673A IL 58673 A IL58673 A IL 58673A IL 58673 A IL58673 A IL 58673A IL 5867379 A IL5867379 A IL 5867379A IL 58673 A IL58673 A IL 58673A
- Authority
- IL
- Israel
- Prior art keywords
- isolation
- membrane proteins
- neisseria meningitidis
- containing same
- vaccines containing
- Prior art date
Links
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 238000013019 agitation Methods 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782848965 DE2848965A1 (de) | 1978-11-11 | 1978-11-11 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL58673A0 IL58673A0 (en) | 1980-02-29 |
| IL58673A true IL58673A (en) | 1983-02-23 |
Family
ID=6054405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL58673A IL58673A (en) | 1978-11-11 | 1979-11-09 | Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0011243B1 (da) |
| JP (1) | JPS5566519A (da) |
| AT (1) | ATE857T1 (da) |
| AU (1) | AU533386B2 (da) |
| CA (1) | CA1142083A (da) |
| DE (2) | DE2848965A1 (da) |
| DK (1) | DK154841C (da) |
| ES (1) | ES485715A1 (da) |
| IL (1) | IL58673A (da) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4317811A (en) | 1980-09-11 | 1982-03-02 | Merck & Co., Inc. | Herpes simplex type 1 subunit vaccine |
| CA1221626A (en) * | 1982-12-02 | 1987-05-12 | Milan Blake | Iga binding protein |
| US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| DE69934225T2 (de) | 1998-05-29 | 2007-09-27 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Kombinierte meningitis b/c impfstoffe |
| ES2563650T3 (es) | 1999-05-19 | 2016-03-15 | Glaxosmithkline Biologicals Sa | Composiciones de combinaciones de Neisseria |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| PT1248647E (pt) | 2000-01-17 | 2010-11-18 | Novartis Vaccines & Diagnostics Srl | Vacina de vesícula da membrana externa (omv) compreendendo proteínas de membrana externa de n. meningitidis do serogrupo b |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| EP1524992B1 (en) | 2002-08-02 | 2015-03-04 | GlaxoSmithKline Biologicals s.a. | Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria menigitidis |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| CA2550927A1 (en) * | 2003-12-23 | 2005-07-14 | Glaxosmithkline Biologicals S.A. | A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| US20090123499A1 (en) | 2006-06-12 | 2009-05-14 | Nathalie Devos | Vaccine |
| BR122016015627A2 (pt) | 2007-10-19 | 2018-10-30 | Novartis Ag | kit, composição antigênica liofilizada e método para preparação de uma composição imunogênica |
| CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
| GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
| WO2010070453A2 (en) | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
| US9517263B2 (en) | 2009-06-10 | 2016-12-13 | Glaxosmithkline Biologicals Sa | Benzonaphthyridine-containing vaccines |
| EP3017828A1 (en) | 2009-08-27 | 2016-05-11 | GlaxoSmithKline Biologicals SA | Hybrid polypeptides including meningococcal fhbp sequences |
| EP2470205A1 (en) | 2009-08-27 | 2012-07-04 | Novartis AG | Adjuvant comprising aluminium, oligonucleotide and polycation |
| TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為ｔｌｒ活性調節劑之化合物及組合物 |
| GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
| EP2483390A2 (en) | 2009-09-30 | 2012-08-08 | Novartis AG | Expression of meningococcal fhbp polypeptides |
| CN102917730A (zh) | 2009-10-27 | 2013-02-06 | 诺华有限公司 | 修饰的脑膜炎球菌fHBP多肽 |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| CN102762206A (zh) | 2009-12-15 | 2012-10-31 | 诺华有限公司 | 免疫增强化合物的均匀悬液及其用途 |
| US20130004530A1 (en) | 2010-03-10 | 2013-01-03 | Jan Poolman | Vaccine composition |
| WO2012020326A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
| EA023725B1 (ru) | 2010-03-23 | 2016-07-29 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
| WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
| ES2654613T3 (es) | 2012-02-02 | 2018-02-14 | Glaxosmithkline Biologicals Sa | Promotores para una expresión aumentada de proteínas en meningococos |
| JP2015517089A (ja) | 2012-03-08 | 2015-06-18 | ノバルティス アーゲー | タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ |
| NZ630133A (en) | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
| CA2882619A1 (en) | 2012-09-06 | 2014-03-13 | Novartis Ag | Combination vaccines with serogroup b meningococcus and d/t/p |
| JP6283674B2 (ja) | 2012-09-18 | 2018-02-21 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 外膜小胞 |
| RS61246B1 (sr) | 2014-02-28 | 2021-01-29 | Glaxosmithkline Biologicals Sa | Modifikovani meningokokni fhbp polipeptidi |
| US12161707B2 (en) | 2016-09-02 | 2024-12-10 | Glaxosmithkline Biologicals Sa | Vaccines for Neisseria gonorrhoeae |
| AU2018330322A1 (en) | 2017-09-08 | 2020-03-19 | Evelo Biosciences, Inc. | Bacterial extracellular vesicles |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| CA3117867A1 (en) | 2018-11-06 | 2020-05-14 | Glaxosmithkline Biologicals Sa | Immunogenic compositions |
| EP3799884A1 (en) | 2019-10-01 | 2021-04-07 | GlaxoSmithKline Biologicals S.A. | Immunogenic compositions |
| GB202115072D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
| GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
| GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
-
1978
- 1978-11-11 DE DE19782848965 patent/DE2848965A1/de not_active Withdrawn
-
1979
- 1979-11-06 ES ES485715A patent/ES485715A1/es not_active Expired
- 1979-11-08 EP EP79104391A patent/EP0011243B1/de not_active Expired
- 1979-11-08 AT AT79104391T patent/ATE857T1/de not_active IP Right Cessation
- 1979-11-08 DE DE7979104391T patent/DE2962526D1/de not_active Expired
- 1979-11-09 AU AU52682/79A patent/AU533386B2/en not_active Ceased
- 1979-11-09 DK DK475779A patent/DK154841C/da not_active IP Right Cessation
- 1979-11-09 IL IL58673A patent/IL58673A/xx unknown
- 1979-11-09 CA CA000339541A patent/CA1142083A/en not_active Expired
- 1979-11-09 JP JP14456179A patent/JPS5566519A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IL58673A0 (en) | 1980-02-29 |
| EP0011243A1 (de) | 1980-05-28 |
| DK475779A (da) | 1980-05-12 |
| CA1142083A (en) | 1983-03-01 |
| DK154841B (da) | 1988-12-27 |
| JPS5566519A (en) | 1980-05-20 |
| DE2848965A1 (de) | 1980-05-22 |
| DK154841C (da) | 1989-06-05 |
| AU5268279A (en) | 1980-05-15 |
| ATE857T1 (de) | 1982-04-15 |
| AU533386B2 (en) | 1983-11-24 |
| EP0011243B1 (de) | 1982-04-14 |
| DE2962526D1 (en) | 1982-05-27 |
| ES485715A1 (es) | 1980-05-16 |
| JPS6350332B2 (da) | 1988-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2962526D1 (en) | Process for preparing membrane proteins from neisseria meningitidis and vaccines containing them | |
| DE69423383D1 (de) | Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken | |
| ATE195420T1 (de) | Methode zur herstellung von eicosapentansäuren | |
| DE69116305D1 (de) | Verfahren zur Herstellung von Trehalulose und Isomaltulose | |
| HUT50863A (en) | Amperometric process for quantitative statement of 1,4 dihydronicotinamid adenin dinucleotid /nadh/ in solution | |
| DE68917329D1 (de) | Malolaktische Fermentation von Wein. | |
| JPS6452726A (en) | Method for removing endotoxin of pertussis, pertussis toxoid and production thereof | |
| HUT44422A (en) | Method and apparatus for improving the quality of roasted coffee | |
| EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
| ATA7285A (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
| YU183587A (en) | Process for obtaining liquid ethanole extract of propolis | |
| ZA908801B (en) | Process for purifying antigenic factors from b.pertussis | |
| EP0607593A3 (de) | Verfahren zur Gewinnnung von Zellkulturen mit erhöhtem Gehalt an körpereigenen Zytokinen. | |
| ATE72756T1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
| DE3574269D1 (en) | Apparatus for the separation of products from a product-substrate mixture | |
| DE3265664D1 (en) | Process for the production of a biochemical vaccine against salmonella fevers | |
| FR2620726B1 (fr) | Procede de preparation d'un extrait de jasmin et extrait obtenu | |
| DE3366707D1 (en) | Preparation of glucose dehydrogenase | |
| EP0281978A3 (en) | Inactivation of human immunodeficiency virus (hiv) in proteinic solutions by means of phenol | |
| GR3003137T3 (en) | Process for the preparation of polychlorophosphazene | |
| PT96134A (pt) | Processo de obtencao de mutantes da oncostatina m | |
| GB2018755A (en) | Benzylidene esters | |
| JPS6410950A (en) | Elimination of taste and odor of substance rich in amino acid | |
| UA14449A1 (uk) | Спосіб отримаhhя паhтокриhа для іh'єкцій | |
| Lillich et al. | Analysis of the intracellular amino acid pool and proteins from whole cells of Rhizobium japonicum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HP | Change in proprietorship | ||
| KB | Patent renewed |